Science
Understanding our scientific approaches
AB Science is a company that designs and develops novel drugs in the field of protein kinases, key enzymes in intracellular signalling pathways.
Our science is based on a research network of internationally renowned scientists working in basic, preclinical and clinical research.
Masitinib is a tyrosine kinase inhibitor that targets mast cells and microglia in particular, cells involved in inflammatory and neuroimmune processes.
AB Science is also developing a second compound, AB8939, in oncology.